Skip to main content

Day: September 26, 2024

Fireweed Grows Boundary Zone, Intersecting 92.15 m of 8.61% Zinc, 2.60% Lead, and 42.7 g/t Silver, Including 11.21 m of 21.40% Zinc, 6.66% Lead, and 107.6 g/t Silver at the Macpass Project

VANCOUVER, British Columbia, Sept. 26, 2024 (GLOBE NEWSWIRE) — FIREWEED METALS CORP. (“Fireweed” or the “Company”) (TSXV: FWZ; OTCQX: FWEDF) is pleased to report the initial results of the 2024 drill campaign, announce the appointment of Graham Richardson as the Company’s CFO, and provide an update on the exploration program at its Macpass Project, Yukon, Canada. HighlightsHole NB24-001 intersected 92.15 m of 8.61% zinc, 2.60% lead, and 42.7 g/t silver (37 m true width), including 11.21 m of 21.40% zinc, 6.66% lead, and 107.6 g/t silver (4.5 m true width). Vein and replacement mineralization intersected in NB24-008 is a 160 m step out to the west from previous drilling, while the stratiform massive sulphide intercepted in NB24-001 is a 65 m intercept west of previous drilling. Expansion of the drill program to over 16,000 m across...

Continue reading

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment

THE WOODLANDS, TX, Sept. 26, 2024 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated, today announced the next CEO Corner segment has been published on the Company’s website. For the CEO Corner segment, Brad Hauser, CEO of Autonomix, addressed Pain Awareness Month and what the Company is doing to address the significant unmet need in pancreatic cancer pain. The CEO Corner segment is now available here. About Autonomix Medical, Inc. Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system...

Continue reading

Verano Announces the Opening of Zen Leaf™ Arcadia in Prime New Phoenix Location

Zen Leaf Arcadia, formerly known as Local Joint, relocated from E University Drive to its new home at 2710 E Indian School Road in Phoenix, a busy thoroughfare with more than 54,000 daily vehicles1 Opening Zen Leaf Arcadia follows Verano’s recent acquisition of Arizona and Virginia operations from The Cannabist Company, elevating the Company’s Arizona operational footprint to eight retail locations and 90,000 square feet of cultivation and processing capacity Verano’s active operations span 14 states, comprised of 152 dispensaries and 15 cultivation and processing facilities with more than 1.1 million square feet of cultivation capacityCHICAGO, Sept. 26, 2024 (GLOBE NEWSWIRE) — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the grand opening...

Continue reading

Goliath Upsizes Non-Brokered Private Placement From $15,725,500 To $16,120,500

TORONTO, Sept. 26, 2024 (GLOBE NEWSWIRE) — Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) (FSE: B4IF) (the “Company” or “Goliath”) is pleased to announce it has increased the previously announced non-brokered flow through financing from $15,725,500 to $16,120,500. Offering Details The non-brokered private placement is a combination of: (i) Charity Flow-Through shares (CFT) to be sold at a price of $1.975 each with no warrant and the Flow-Through shares (FT) to be sold at a price of $1.44 each with no warrant. These shares will qualify as a flow-through share within the meaning of Subsection 66(15) of the Income Tax Act (Canada). The first tranche closed on September 13, 2024 that consisted of 3,018,000 CFT shares for proceeds of $5,960,550 and 2,501,221 FT shares for proceeds of $3,601,758 for aggregate proceeds of $9,562,308....

Continue reading

Pasithea Therapeutics Announces Positive Initial Safety, Tolerability, Pharmacokinetic (PK), and Preliminary Efficacy Data from its Phase 1 Clinical Trial of PAS-004 in Advanced Cancer

— Single patient in 2mg cohort with stage 3 colon cancer who received 4 prior lines of therapy achieves prolonged stable disease and remains on drug into 6th dosing cycle — — No treatment-related adverse events (TRAEs) or dose-limiting toxicities (DLTs) observed to date, including no rash or gastrointestinal (GI) AEs — — Systemic exposure at steady-state enables constant target inhibition while avoiding peak plasma toxicities — — Half-life of approximately 70 hours supports once-daily or less frequent oral dosing — — Distinctive MEK inhibitor profile for the treatment of both NF1-related plexiform and cutaneous neurofibromas, cancer, and other opportunities — MIAMI, Sept. 26, 2024 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”),...

Continue reading

ForFarmers sharpens its sustainability ambitions for a future-proof agricultural sector

Lochem, 26 September 2024 ForFarmers sharpens its sustainability ambitions for a future-proof agricultural sector ForFarmers is committed to future-proof farming through knowledge, advice, support and products on farm. Sustainability plays an essential role in this and is therefore a fundamental part of its mission ‘For the Future of Farming’. In that context, ForFarmers has further sharpened its sustainability ambitions to be able to support farmers and chain partners in the sector’s transition. ForFarmers aims to reduce its own CO2 emissions by one-third by 2030 compared to the year 2022. In addition, ForFarmers aims to increase the use of circular raw materials by one-third and is committed to protecting biodiversity. One-third reduction of CO2 emissions ForFarmers aims to reduce CO2 emissions from its own operations by...

Continue reading

Hut 8 GPU-as-a-Service Vertical Goes Live with Inaugural Deployment

1,000 NVIDIA H100 GPUs delivered to AI cloud developer Miami, FL, Sept. 26, 2024 (GLOBE NEWSWIRE) — Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a leading, vertically integrated operator of large-scale energy infrastructure and one of North America’s largest Bitcoin miners, today announced that its GPU-as-a-service vertical has begun generating revenue as the inaugural GPU cluster for an AI cloud developer comes fully online. The cluster, hosted at a tier-three data center in Chicago, comprises multiple Hewlett Packard Enterprise (“HPE”) Cray supercomputers powered by 1,000 NVIDIA H100 GPUs. Hut 8 partnered with HPE and AdvizeX to design, configure, and commission the cluster, which is being launched under Hut 8’s subsidiary, Highrise AI, Inc. Hut 8’s five-year agreement with the AI cloud developer provides...

Continue reading

Hut 8 GPU-as-a-Service Vertical Goes Live with Inaugural Deployment

1,000 NVIDIA H100 GPUs delivered to AI cloud developer MIAMI, Sept. 26, 2024 (GLOBE NEWSWIRE) — Hut 8 Corp. (Nasdaq | TSX: HUT) (“Hut 8” or the “Company”), a leading, vertically integrated operator of large-scale energy infrastructure and one of North America’s largest Bitcoin miners, today announced that its GPU-as-a-service vertical has begun generating revenue as the inaugural GPU cluster for an AI cloud developer comes fully online. The cluster, hosted at a tier-three data center in Chicago, comprises multiple Hewlett Packard Enterprise (“HPE”) Cray supercomputers powered by 1,000 NVIDIA H100 GPUs. Hut 8 partnered with HPE and AdvizeX to design, configure, and commission the cluster, which is being launched under Hut 8’s subsidiary, Highrise AI, Inc. Hut 8’s five-year agreement with the AI cloud developer provides for...

Continue reading

Teleflex’s Barrigel Rectal Spacer to Be Featured in Three Presentations at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting

• Highlights include new safety and efficacy data of Barrigel™ rectal spacer, the first and only sculptable rectal spacer1–3 • Teleflex to host Barrigel™ Educational Symposium featuring a physician panel discussion on the Science of Personalized Spacing with Barrigel™ rectal spacer WAYNE, Pa., Sept. 26, 2024 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced three clinical studies4-6 focused on its Barrigel™ rectal spacer are to be presented at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting, which will take place in Washington, DC, from September 29 to October 2, 2024. The featured data will contribute to the expanding body of clinical evidence regarding the safety and efficacy of Barrigel™ rectal...

Continue reading

REE Automotive Provides Corporate and Business Updates and Reports Second Quarter 2024 Financial Results

$45.35 Million Funding Secured, Strategic Manufacturing Agreement with Motherson, U.S. Production Kicked Off, Continued Demand Drives Orderbook to $60 MillionCompleted $45.35 million Registered Direct offering led by M&G and Motherson securing production capital needs Signed strategic agreement with Motherson, a global automotive supplier, to strengthen REE’s supply chain management and cost structure, improve working capital efficiencies and expand outreach to global OEMs Kicked-off U.S. production in Michigan with Roush as contract manufacturer for full vehicle assembly, with start of production planned for Q4 2024 and deliveries in 2025 Narrowed Q2 2024 net loss by 57% QoQ while concurrently reducing free cash flow burn by 19% QoQ Increased order book by 15% QoQ, and by 289% YoY, which is valued at approximately $60 million to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.